Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Healthcare Industry News Know about Vitamin B2 sources, benefits, chemical name, deficiency diseases Vitamin B2 also known as Riboflavin is one of the eight water-soluble vitamins essential for our body. Let… bypharmanewsdailyApril 7, 2018
